Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 834 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 511.80 USD | -0.96% | -0.43% | -7.78% | +20.82% | 11.82 B USD | ||
| 861 | TECH Bio-Techne Corp - Common Stock | 72.36 USD | +0.06% | -0.03% | +0.98% | +27.26% | 11.33 B USD | ||
| 876 | AXSM Axsome Therapeutics, Inc. - Common Stock | 206.30 USD | -0.71% | -3.80% | -14.20% | +58.45% | 10.81 B USD | ||
| 886 | CYTK Cytokinetics, Incorporated - Common Stock | 76.14 USD | -0.91% | +3.06% | -6.59% | +31.05% | 10.59 B USD | ||
| 898 | SMMT Summit Therapeutics Inc. - Common Stock | 12.46 USD | -5.32% | +2.13% | -10.04% | -37.26% | 9.94 B USD | ||
| 899 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 365.98 USD | -2.65% | -3.34% | +12.51% | +658.98% | 10.22 B USD | ||
| 919 | KRYS Krystal Biotech, Inc. - Common Stock | 344.62 USD | -0.57% | +3.76% | +1.63% | +84.16% | 10.20 B USD | ||
| 933 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.54 USD | -0.62% | +1.02% | +24.75% | +98.08% | 9.99 B USD | ||
| 936 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 151.51 USD | -1.82% | -2.06% | +11.31% | +101.66% | 9.80 B USD | ||
| 938 | KYMR Kymera Therapeutics, Inc. - Common Stock | 117.13 USD | -2.23% | -1.16% | +5.93% | +98.19% | 9.74 B USD | ||
| 940 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 60.33 USD | +0.99% | +6.63% | +6.59% | -16.35% | 10.03 B USD | ||
| 963 | SYRE Spyre Therapeutics, Inc. - Common Stock | 105.52 USD | -0.91% | +2.35% | +2.95% | +341.32% | 9.30 B USD | ||
| 969 | PCVX Vaxcyte, Inc. - Common Stock | 61.46 USD | -1.85% | +3.87% | +12.21% | +45.30% | 9.15 B USD | ||
| 978 | IMVT Immunovant, Inc. - Common Stock | 43.66 USD | -1.60% | +3.85% | +9.23% | +127.28% | 9.02 B USD | ||
| 987 | ABVX Abivax SA - American Depositary Shares | 113.87 USD | -0.94% | -5.55% | -9.58% | +47.73% | 8.94 B USD | ||
| 993 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.78 USD | +0.11% | +0.09% | +1.17% | +106.28% | 8.99 B USD | ||
| 1034 | APGE Apogee Therapeutics, Inc. - Common Stock | 134.76 USD | +0.01% | +0.16% | +0.36% | +151.46% | 8.38 B USD | ||
| 1039 | TGTX TG Therapeutics, Inc. - Common Stock | 53.62 USD | -1.20% | +9.54% | -6.42% | +81.95% | 8.21 B USD | ||
| 1045 | IBRX ImmunityBio, Inc. - Common Stock | 7.55 USD | -3.08% | -1.31% | +3.99% | +226.84% | 8.00 B USD | ||
| 1079 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 110.40 USD | +0.36% | -5.27% | +5.50% | +0.08% | 7.60 B USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |